Achillion Pharmaceuticals, Inc. (ACHN) stock prices updated...
 

Achillion Pharmaceuticals, Inc. stock price

Achillion Pharmaceuticals, Inc. latest news:


  • 09/11/2017 01:06:18

    BRIEF-Achillion announces termination of worldwide collaboration for hepatitis c with Janssen

    Achillion Pharmaceuticals Inc(ACHN). * Achillion announces termination of worldwide collaboration for hepatitis c with Janssen Further company coverage:

  • 08/08/2017 15:38:44

    Achillion shares rally as blood disorder treatment shows promise

    Shares of Achillion Pharmaceuticals Inc. surged in the extended session Tuesday after the drug developer met expectations for second-quarter results and said early results of a blood disorder treatment look promising. Achillion shares rallied 33% to $5.35 after hours. The company said four patients so far enrolled in a mid-stage clinical study of ACH-4471, meant to treat paroxysmal nocturnal hemoglobinuria, were responding well to the drug. Paroxysmal nocturnal hemoglobinuria is a rare, acquired condition where the body's immune system destroys red blood cells in error. Achillion also reported a second-quarter loss of $22.5 million, or 16 cents a share, compared with a loss of $18.5 million, or 14 cents a share, in the year-ago period. Analysts surveyed by FactSet had forecast a loss of 16 cents a share.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    ACI Worldwide, Inc.ACIW | ACNB CorporationACNB | Acorda Therapeutics, Inc.ACOR | Actions Semiconductor Co., Ltd.ACTS | Active Power, Inc.ACPW | Activision Blizzard, IncATVI | Actua CorporationACTA | Acura Pharmaceuticals, Inc.ACUR | Acxiom CorporationACXM | Adamas Pharmaceuticals, Inc.ADMS |